Log in to search using one of your social media accounts:


Chest doctors issue guidelines for CT lung cancer screening

An expert panel of chest physicians has updated its guidelines for low-dose...Read more on AuntMinnie.comRelated Reading: New solid nodules may increase lung cancer risk Canadian risk model boosts CT lung screening efficiency Study: CT screening would cut lung cancer deaths in China ARRS: Do NLST results translate to the real world? BMJ: Benefits of CT lung cancer screening outweigh dose
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Australian researchers report finding that lung cancer rates among never-smokers are stable, after US researchers raised the alarm over an apparent doubling in incidence.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Authors: Hayasaka K, Shiono S, Yanagawa N Abstract A 65-year-old man presented with obstructive pneumonia due to squamous cell carcinoma of the lung, which invaded the right main bronchus. Argon plasma coagulation was performed, which reduced his symptoms. Right pneumonectomy was performed after preoperative chemotherapy; the pathological diagnosis was T3N1M0 Stage IIIA. Fifteen months after surgery, he presented with bloody sputum. Bronchoscopy showed multiple endotracheal tumors, and a pathological examination revealed squamous cell carcinoma; the same histology as the primary lung cancer. We hypothesized that di...
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Authors: Hayashi N, Fujita A, Saikai T, Takabatake H, Sotoshiro M, Sekine K, Kawana A Abstract Anaplastic lymphoma kinase (ALK) rearrangement is most commonly observed in lung adenocarcinoma in a subset of lung cancer. Large-cell neuroendocrine carcinoma (LCNEC) harboring an ALK rearrangement is very rare. Based on the findings from a transbronchial lung biopsy, a 75-year-old non-smoking woman was diagnosed with LCNEC with multiple liver and bone metastases. After seven cycles of cytotoxic chemotherapy, her genotype testing demonstrated ALK rearrangement. Subsequently, she was administered alectinib and exhibited a...
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
Lung cancer kills approximately 158,000 yearly, accounting for more deaths than the next 4 most lethal types of cancer combined.1 In 2011, the National Lung Screening Trial demonstrated a 20% reduction in lung cancer deaths with the use of a low-dose CT scan in select high-risk populations.2
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Letter Source Type: research
Condition:   EGF-R Positive Non-Small Cell Lung Cancer Intervention:   Drug: Icotinib Sponsor:   Betta Pharmaceuticals Co.,Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Non-small Cell Lung Cancer Interventions:   Drug: Nivolumab;   Drug: Epacadostat;   Drug: Placebo;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: Paclitaxel;   Drug: Pemetrexed Sponsors:   Incyte Corporation;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Stage I Non-Small Cell Lung Cancer AJCC v7;   Stage IA Non-Small Cell Lung Carcinoma AJCC v7;   Stage IB Non-Small Cell Lung Carcinoma AJCC v7;   Stage II Non-Small Cell Lung Cancer AJCC v7;   Stage IIA Non-Small Cell Lung Carcinoma AJCC v7;   Stage IIB  Non-Small Cell Lung Carcinoma AJCC v7;   Stage IIIA Non-Small Cell Lung Cancer AJCC&nb...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSIONS: PRR11 may be a weak prognostic indicator of overall survival of patients with non-mucinous invasive adenocarcinoma of the lung. PMID: 29154370 [PubMed - in process]
Source: Pathologica - Category: Pathology Tags: Pathologica Source Type: research
Close-up of a woman hands hold and broke a cigarette. Credit: BigstockBy Thalif DeenUNITED NATIONS, Nov 21 2017 (IPS)Back in November 2008, the 193-member General Assembly decided, by consensus, to ban smoking and tobacco sales at the UN headquarters in New York: a ruling observed by all affiliated agencies worldwide, including the Geneva-based World Health Organization (WHO) which has severed links with the tobacco industry. But there still remains one holdout: the 187-member International Labour Organization (ILO) in Geneva whose Governing Body, which meets three times a year, has postponed once again its decision on whe...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Development & Aid Global Headlines Health Poverty & SDGs TerraViva United Nations Source Type: news
Lung cancer 2017: Giant steps and stumbling blocks, Published online: 21 November 2017; doi:10.1038/nrclinonc.2017.178In 2017, major advances in the treatment of non-small-cell lung cancer (NSCLC) continued to emanate from the fields of molecularly targeted therapy and immunotherapy. In the former, new drugs with improved efficacy and reduced toxicity entered the clinic; in the latter, immune-checkpoint inhibition proved efficacious after chemoradiotherapy for stage III disease, but had disparate results in the frontline treatment of stage IV disease.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | China Health | Lung Cancer | Radiology | Study